Pages

Monday, October 2, 2017

FDA Law Blog: NOTE TO COMMISSIONER GOTTLIEB AND CONGRESS: FDA Has Ignored Congressional Intent and Broken its Commitment to Congress to Develop NDI Policies Consistent with the FDC Act as Modified by DSHEA